These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15587503)

  • 1. Nuclear receptors: old targets, new opportunities.
    Asadullah K; Metternich R
    Curr Drug Targets Inflamm Allergy; 2004 Dec; 3(4):333-4. PubMed ID: 15587503
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear hormone receptors and intestinal inflammation.
    Wu GD
    Gastroenterology; 2007 Oct; 133(4):1068. PubMed ID: 17919480
    [No Abstract]   [Full Text] [Related]  

  • 3. Orphan nuclear receptors in drug discovery.
    Shi Y
    Drug Discov Today; 2007 Jun; 12(11-12):440-5. PubMed ID: 17532527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areas.
    Sladek FM
    Expert Opin Ther Targets; 2003 Oct; 7(5):679-84. PubMed ID: 14498828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.
    Straus DS; Glass CK
    Trends Immunol; 2007 Dec; 28(12):551-8. PubMed ID: 17981503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role reversal: new insights from new ligands for the xenobiotic receptor CAR.
    Tzameli I; Moore DD
    Trends Endocrinol Metab; 2001; 12(1):7-10. PubMed ID: 11137034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PPARs: from orphan receptors to drug discovery.
    Willson TM; Brown PJ; Sternbach DD; Henke BR
    J Med Chem; 2000 Feb; 43(4):527-50. PubMed ID: 10691680
    [No Abstract]   [Full Text] [Related]  

  • 9. New dermatological agents for the treatment of psoriasis.
    Thacher SM; Vasudevan J; Tsang KY; Nagpal S; Chandraratna RA
    J Med Chem; 2001 Feb; 44(3):281-97. PubMed ID: 11462969
    [No Abstract]   [Full Text] [Related]  

  • 10. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
    Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptors and atherosclerosis.
    Lala DS
    IDrugs; 2004 Jun; 7(6):563-9. PubMed ID: 15197661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel antiinflammatory targets for asthma. A role for PPARgamma?
    Serhan CN; Devchand PR
    Am J Respir Cell Mol Biol; 2001 Jun; 24(6):658-61. PubMed ID: 11415929
    [No Abstract]   [Full Text] [Related]  

  • 13. Nuclear hormone receptor assays for drug discovery.
    Rosen J; Marschke K; Rungta D
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):224-30. PubMed ID: 12669458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
    Wang H; LeCluyse EL
    Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.
    Chao EY; Caravella JA; Watson MA; Campobasso N; Ghisletti S; Billin AN; Galardi C; Wang P; Laffitte BA; Iannone MA; Goodwin BJ; Nichols JA; Parks DJ; Stewart E; Wiethe RW; Williams SP; Smallwood A; Pearce KH; Glass CK; Willson TM; Zuercher WJ; Collins JL
    J Med Chem; 2008 Sep; 51(18):5758-65. PubMed ID: 18800767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonsteroidal anti-rheumatic drugs and colon carcinoma: COX versus PPAR].
    Wächtershäuser A; Stein J
    Z Gastroenterol; 1999 Mar; 37(3):257-61. PubMed ID: 10234800
    [No Abstract]   [Full Text] [Related]  

  • 17. Orphan nuclear receptors--new ligands and new possibilities.
    Blumberg B; Evans RM
    Genes Dev; 1998 Oct; 12(20):3149-55. PubMed ID: 9784489
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.
    Yu Y; Correll PH; Vanden Heuvel JP
    Biochim Biophys Acta; 2002 Apr; 1581(3):89-99. PubMed ID: 12020636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
    Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
    Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.